BioSpace News Archive

Gnubiotics Sciences SA, a Swiss biotech company pioneering novel microbiome targeted solutions for humans and companion animals, announced the allowance from the European Patent Office for its patent application 19812838.1.

Akeso, Inc. announced that Penpulimab, an PD-1 monoclonal antibody drug co-developed by the Company with Sino Biopharmaceutical Limited, has submitted a Biologics License Application to the Food and Drug Administration of the United States for third-line treatment of metastatic nasopharyngeal carcinoma.

Stemedica Cell Technologies, Inc., a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced that it has signed a Licensing Agreement with Pulthera, LLC for the rights to use, distribute and sell its mesenchymal stem cell technologies in the treatment of COVID-19 and additional pulmonary conditions.

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 2021 Jefferies Virtual Healthcare Conference.